Aethlon Medical Statistics

Total Valuation

AEMD has a market cap or net worth of $5.43 million. The enterprise value is -$626,457.

Market Cap	5.43M
Enterprise Value	-626,457

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

AEMD has 13.94 million shares outstanding. The number of shares has increased by 179.52% in one year.

Current Share Class	13.94M
Shares Outstanding	13.94M
Shares Change (YoY)	+179.52%
Shares Change (QoQ)	+86.88%
Owned by Insiders (%)	0.72%
Owned by Institutions (%)	2.91%
Float	13.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.90
P/TBV Ratio	0.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.13.

Current Ratio	3.06
Quick Ratio	2.94
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -137.96% and return on invested capital (ROIC) is -73.52%.

Return on Equity (ROE)	-137.96%
Return on Assets (ROA)	-61.78%
Return on Capital (ROIC)	-73.52%
Revenue Per Employee	n/a
Profits Per Employee	-$804,997
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.08% in the last 52 weeks. The beta is 1.75, so AEMD's price volatility has been higher than the market average.

Beta (5Y)	1.75
52-Week Price Change	-76.08%
50-Day Moving Average	0.40
200-Day Moving Average	0.82
Relative Strength Index (RSI)	47.61
Average Volume (20 Days)	426,130

Short Selling Information

The latest short interest is 286,148, so 2.05% of the outstanding shares have been sold short.

Short Interest	286,148
Short Previous Month	299,323
Short % of Shares Out	2.05%
Short % of Float	2.07%
Short Ratio (days to cover)	0.98

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.71M
Pretax Income	-12.21M
Net Income	-11.27M
EBITDA	-10.36M
EBIT	-10.71M
Earnings Per Share (EPS)	-$1.70

Full Income Statement

Balance Sheet

The company has $6.86 million in cash and $798,452 in debt, giving a net cash position of $6.06 million or $0.43 per share.

Cash & Cash Equivalents	6.86M
Total Debt	798,452
Net Cash	6.06M
Net Cash Per Share	$0.43
Equity (Book Value)	6.02M
Book Value Per Share	0.43
Working Capital	4.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.91 million and capital expenditures -$13,714, giving a free cash flow of -$8.92 million.

Operating Cash Flow	-8.91M
Capital Expenditures	-13,714
Free Cash Flow	-8.92M
FCF Per Share	-$0.64

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AEMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-179.52%
Shareholder Yield	-179.52%
Earnings Yield	-207.39%
FCF Yield	-164.13%

Analyst Forecast

The average price target for AEMD is $7.00, which is 1,695.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	1,695.33%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 5, 2023. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Oct 5, 2023
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1